Lymphoproliferative disorders in the immunosuppressed

Diagnostic Histopathology

Volumn 16, Issue 4, 2010, Pages 206-215

  Naresh, Kikkeri N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

AIDS; HIV; immune suppression; lymphomas; lymphoproliferative disorders

Indexed keywords

ADALIMUMAB; CD8 ANTIGEN; ETANERCEPT; INFLIXIMAB; METHOTREXATE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BURKITT LYMPHOMA; CELL EXPANSION; CELL PROLIFERATION; CELL STRUCTURE; CLASSICAL HODGKIN LYMPHOMA; CLONAL VARIATION; COMMON VARIABLE IMMUNODEFICIENCY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FOLLOW UP; HISTIOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; NK T CELL LYMPHOMA; PATIENT CARE; PERIPHERAL T CELL LYMPHOMA; PLASMA CELL; POPULATION; PRIMARY EFFUSION LYMPHOMA;

EID: 77949263032     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.12.014     Document Type: Article

References (65)

1. Nalesnik M.A., Randhawa P., Demetris A.J., Casavilla A., Fung J.J., and Locker J. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer 72 (1993 Nov 1) 2568-2573
2. Greiner T., Armitage J.O., and Gross T.G. Atypical lymphoproliferative diseases. Hematology Am Soc Hematol Educ Program (2000) 133-146
3. Kwong Y.L., Lam C.C., and Chan T.M. Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis. Br J Haematol 110 (2000 Jul) 197-202
4. Chadburn A., Suciu-Foca N., Cesarman E., Reed E., Michler R.E., and Knowles D.M. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol 147 (1995 Dec) 1862-1870
5. Zutter M.M., Martin P.J., Sale G.E., et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72 (1988 Aug) 520-529
6. Van Krieken J.H., Onciu M., Elenitoba-Johnson K.S.J., and Jaffe E.S. Lymphoproliferative diseases associated with primary immune disorders. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC, Lyon, France 336-339
7. Sander C.A., Medeiros L.J., Weiss L.M., Yano T., Sneller M.C., and Jaffe E.S. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 16 (1992 Dec) 1170-1182
8. Chiaramonte C., and Glick S.N. Nodular lymphoid hyperplasia of the small bowel complicated by jejunal lymphoma in a patient with common variable immune deficiency syndrome. AJR Am J Roentgenol 163 (1994 Nov) 1118-1119
9. Jesus A.A., Duarte A.J., and Oliveira J.B. Autoimmunity in hyper-IgM syndrome. J Clin Immunol 28 (2008 May) S62-S66
10. Sneller M.C., Dale J.K., and Straus S.E. Autoimmune lymphoproliferative syndrome. Curr Opin Rheumatol 15 (2003 Jul) 417-421
11. Lim M.S., Straus S.E., Dale J.K., et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol 153 (1998 Nov) 1541-1550
12. Boutros N., Hawkins D., Nelson M., Lampert I.A., and Naresh K.N. Burkitt lymphoma and Leishmaniasis in the same tissue sample in an AIDS patient. Histopathology 48 (2006 Jun) 880-881
13. Piris M.A., Rivas C., Morente M., Rubio C., Martin C., and Olivia H. Persistent and generalized lymphadenopathy: a lesion of follicular dendritic cells? An immunohistologic and ultrastructural study. Am J Clin Pathol 87 (1987 Jun) 716-724
14. de Paiva G.R., Laurent C., Godel A., et al. Discovery of human immunodeficiency virus infection by immunohistochemistry on lymph node biopsies from patients with unexplained follicular hyperplasia. Am J Surg Pathol 31 (2007 Oct) 1534-1538
15. Turner R.R., Meyer P.R., Taylor C.R., et al. Immunohistology of persistent generalized lymphadenopathy. Evidence for progressive lymph node abnormalities in some patients. Am J Clin Pathol 88 (1987 Jul) 10-19
16. Biberfeld P., Porwit-Ksiazek A., Böttiger B., Morfeldt-Månsson L., and Biberfeld G. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res 45 (1985 Sep) 4665s-4670s
17. Moonim MT, Alarcon L, Freeman J, Mahadeva U, Van der Walt JD, Lucas SB. Identifying HIV infection in diagnostic histopathology tissue samples - the role of HIV-1 p24 immunohistochemistry in identifying clinically unsuspected HIV infection: a 3 year analysis. Histopathology, in press.
18. Franco-Paredes C., Rebolledo P., Folch E., Hernandez I., and del Rio C. Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read 12 (2002 Sep) 408-413
19. Smith P.R., Cavenagh J.D., Milne T., et al. Benign monoclonal expansion of CD8+ lymphocytes in HIV infection. J Clin Pathol 53 (2000 Mar) 177-181
20. Burke A.P., Anderson D., Mannan P., et al. Systemic lymphadenopathic histology in human immunodeficiency virus-1-seropositive drug addicts without apparent acquired immunodeficiency syndrome. Hum Pathol 25 (1994 Mar) 248-256
21. Karcher D.S., and Frost A.R. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. Am J Clin Pathol 95 (1991 Jan) 63-71
22. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129 (2005) 3-17
23. Moore P.S., and Chang Y. Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr 23 (1998) 65-71
24. Dupin N., Diss T.L., Kellam P., et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95 (2000 Feb 15) 1406-1412
25. Du M.Q., Liu H., Diss T.C., et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97 (2001 Apr 1) 2130-2136
26. Naresh K.N., Trivedi P., Horncastle D., and Bower M. CD20 expression in the HHV-8-infected lymphoid cells in multicentric Castleman disease. Histopathology 55 3 (2009 Sep) 358-359
27. Isaacson P.G., Campo E., and Harris N.L. Large B-cell lymphoma arising in HHV-8 associated multicentric Castleman disease. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC, Lyon, France 258-259
28. Naresh K.N., Rice A.J., and Bower M. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma. Am J Surg Pathol 32 (2008 Jul) 1006-1012
29. Bower M., Powles T., Williams S., et al. Brief communication: rituximab in HIV-associated multicentric Castleman disease. Ann Intern Med 147 (2007 Dec 18) 836-839
30. Castillo J., Pantanowitz L., and Dezube B.J. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 83 (2008 Oct) 804-809
31. Delecluse H.J., Anagnostopoulos I., Dallenbach F., et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89 (1997 Feb 15) 1413-1420
32. Stein H., Harris N.L., and Campo E. Plasmablastic lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC, Lyon, France 256-257
33. Colomo L., Loong F., Rives S., et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28 (2004 Jun) 736-747
34. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332 (1995 May 4) 1186-1191
35. Said J., and Cesarman E. Primary effusion lymphoma. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC, Lyon, France 260-261
36. Gaidano G., and Carbone A. Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities. Adv Cancer Res 80 (2001) 115-146
37. Chadburn A., Hyjek E., Mathew S., Cesarman E., Said J., and Knowles D.M. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 28 (2004 Nov) 1401-1416
38. Raphael M., Said J., Borisch B., Cesarman E., and Harris N.L. Lymphomas associated with HIV infection. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC, Lyon, France 340-342
39. Grogg K.L., Miller R.F., and Dogan A. HIV infection and lymphoma. J Clin Pathol 60 (2007) 1365-1372
40. Tirelli U., Errante D., Dolcetti R., et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13 (1995) 1758-1767
41. Said J.W. Immunodeficiency-related Hodgkin lymphoma and its mimics. Adv Anat Pathol 14 (2007) 189-194
42. Rezk S.A., and Weiss L.M. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 38 (2007) 1293-1304
43. Carbone A., Gloghini A., Serraino D., and Spina M. HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS 4 (2009 Jan) 3-10
44. Spina M., Tirelli U., Zagonel V., et al. Burkitt's lymphoma in adults with and without human immunodeficiency virus infection. Cancer 82 (1998) 766-774
45. Ponzoni M., Fumagalli L., Rossi G., et al. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 15 (2002 Dec) 1273-1278
46. Stebbing J., Ngan S., Ibrahim H., et al. The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease. Clin Exp Immunol 154 (2008 Dec) 399-405
47. Poirel H.A., Bernheim A., Schneider A., et al. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status. Transplantation 80 (2005 Jul 27) 176-184
48. Chan J.K.-C. Post-transplant lymphoproliferative disorders: a simplified overview. Hong Kong J Nephrol 3 (2001 Oct) 57-66
49. Dharnidharka V.R., Sullivan E.K., Stablein D.M., Tejani A.H., and Harmon W.E. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71 (2001 Apr 27) 1065-1068
50. Cockfield S.M. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 3 (2001 Jun) 70-78
51. Green M., Reyes J., Webber S., and Rowe D. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 3 (2001 Jun) 97-103
52. Swerdlow S.H., Webber S.A., Chadburn A., and Ferry J.A. Post-transplant lymphoproliferative disorders. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC, Lyon, France 343-349
53. Leblond V., Sutton L., Dorent R., et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 13 (1995 Apr) 961-968
54. Hoshida Y., Li T., Dong Z., et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 91 (2001 Mar 15) 869-875
55. Ghobrial I.M., Habermann T.M., Macon W.R., et al. Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?. Transplantation 79 (2005 Jan 27) 244-247
56. Nelson B.P., Nalesnik M.A., Bahler D.W., Locker J., Fung J.J., and Swerdlow S.H. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?. Am J Surg Pathol 24 (2000 Mar) 375-385
57. Kapelushnik J., Ariad S., Benharroch D., et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol 113 (2001 May) 425-428
58. Knowles D.M., Cesarman E., Chadburn A., et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85 (1995 Jan 15) 552-565
59. Chetty R., Biddolph S., and Gatter K. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Sternberg-like cells in non-Hodgkin's lymphomas and reactive conditions. Hum Pathol 28 (1997 Apr) 493-498
60. Capello D., Rossi D., and Gaidano G. Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis. Hematol Oncol 23 (2005 Jun) 61-67
61. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004 Jan 1) 275-282
62. Capello D., Cerri M., Muti G., et al. Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood 102 (2003 Nov 15) 3775-3785
63. Kaplan M.A., Ferry J.A., Harris N.L., and Jacobson J.O. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. Am J Clin Pathol 101 (1994 May) 590-596
64. Rowlings P.A., Curtis R.E., Passweg J.R., et al. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol 17 (1999 Oct) 3122-3127
65. Gaulard P., Swerdlow S.H., Harris N.L., Jaffe E.S., and Sundstrom C. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC, Lyon, France 350-351